Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies (Q38097263)

From Wikidata

Jump to navigation Jump to search

scientific article published on 06 April 2013

Language	Label	Description	Also known as
English	Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies	scientific article published on 06 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

28 August 2017

1 reference

3 October 2022

Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies (English)

1 reference

Europe PubMed Central

28 August 2017

0 references

primary effusion lymphoma

1 reference

3 October 2022

author name string

Arun George Paul

1

1 reference

Europe PubMed Central

28 August 2017

Bala Chandran

2

1 reference

Europe PubMed Central

28 August 2017

Neelam Sharma-Walia

3

1 reference

Europe PubMed Central

28 August 2017

publication date

6 April 2013

1 reference

Europe PubMed Central

28 August 2017

1 August 2013

1 reference

3 October 2022

Translational Research

1 reference

Europe PubMed Central

28 August 2017

162

1 reference

Europe PubMed Central

28 August 2017

77-92

1 reference

Europe PubMed Central

28 August 2017

2

1 reference

Europe PubMed Central

28 August 2017

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inflammation and cancer: back to Virchow?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Prostaglandins and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inflammation: gearing the journey to cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human tumor-associated viruses and new insights into the molecular mechanisms of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The cyclooxygenases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

COX-2 and cancer: a new approach to an old problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenases in cancer: progress and perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Eicosanoids and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The stability of 13,14-dihydro-15 keto-PGE2

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Prostaglandin E receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Positive and negative regulation of NF-kappaB by COX-2: roles of different prostaglandins

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Pro-inflammatory prostaglandins and progression of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

AH6809 antagonizes non-small cell lung cancer prostaglandin receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Targeting prostaglandin E EP receptors to inhibit metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Prostanoid receptor signaling relevant to tumor growth and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E2 in RNA Replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

COX-2 Induction during Murine Gammaherpesvirus 68 Infection Leads to Enhancement of Viral Gene Expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The role and regulation of COX-2 during viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Immunosuppression by canine distemper virus: modulation of in vitro immunoglobulin synthesis, interleukin release and prostaglandin E2 production

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Biological interactions between herpesviruses and cyclooxygenase enzymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human cytomegalovirus induced cyclooxygenase-2 in human retinal pigment epithelial cells augments viral replication through a prostaglandin pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

EBV suppresses prostaglandin E2 biosynthesis in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

NFAT and CREB regulate Kaposi's sarcoma-associated herpesvirus-induced cyclooxygenase 2 (COX-2)

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-v-FLIP.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

HHV-8-associated lymphoma: state-of-the-art review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

KSHV infection and the pathogenesis of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

HIV-associated lymphomas and gamma-herpesviruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma: a computational approach through protein-protein interaction and gene regulatory networks analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma and its associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The tumor microenvironment controls primary effusion lymphoma growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Structure and function of latency-associated nuclear antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-κB pathway independent of TRAF6, TAK1 and LUBAC.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

p53 inhibition by the LANA protein of KSHV protects against cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

FLIP-mediated autophagy regulation in cell death control

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The use of nimesulide and its analogues in cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Celecoxib toxicity is cell cycle phase specific

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?]

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Rapalogs in viral cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Celecoxib and Bcl-2: emerging possibilities for anticancer drug design

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

DNA damage checkpoints in stem cells, ageing and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Hit proteins, mitochondria and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Molecular mechanisms mediating metastasis of hypoxic breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Death pathways triggered by activated Ras in cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Common fragile sites, extremely large genes, neural development and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Virus and cell RNAs expressed during Epstein-Barr virus replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epstein-Barr virus-specific methylation of human genes in gastric cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Transcriptional repression of TWIST1 gene by Prospero-related homeobox 1 inhibits invasiveness of hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Syndecans shed their reputation as inert molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Aquaporins--new players in cancer biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's Sarcoma Associated Herpesvirus Entry into Target Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi's sarcoma-associated herpesvirus infection in endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ( V 5, V 3, and 3 1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.03.004

7 January 2021

EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemopreventive response of diclofenac, a non-steroidal anti-inflammatory drug in experimental carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review).

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TP53 and mutations in human cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complement and infectious agents: a tale of disguise and deception

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Promoter methylation of tumor-related genes in gastric carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nimesulide inhibits proliferationviainduction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Why cancer and inflammation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epithelial E- and P-cadherins: role and clinical significance in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23567332

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.TRSL.2013.03.004

1 reference

Europe PubMed Central

28 August 2017

0 references

1 reference

Europe PubMed Central

28 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38097263&oldid=1742044592"